Vasopressin, arginine (DrugBank: Vasopressin, Arginine)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
210 | 単心室症 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03088345 (ClinicalTrials.gov) | March 6, 2017 | 28/2/2017 | Early Use of Vasopressin in Post-Fontan Management | Use of Arginine Vasopressin in Early Postoperative Management After Fontan Palliation | Circulatory Perfusion Disorder;Congenital Heart Disease;Single-ventricle | Drug: Vasopressin, Arginine;Drug: Placebo | Medical College of Wisconsin | NULL | Completed | N/A | 18 Years | All | 20 | Phase 2;Phase 3 | United States |